Aprogen Healthcare (Korea) Performance
109960 Stock | KRW 475.00 12.00 2.46% |
The firm shows a Beta (market volatility) of -0.19, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Aprogen Healthcare are expected to decrease at a much lower rate. During the bear market, Aprogen Healthcare is likely to outperform the market. At this point, Aprogen Healthcare Games has a negative expected return of -0.63%. Please make sure to confirm Aprogen Healthcare's jensen alpha, treynor ratio, value at risk, as well as the relationship between the total risk alpha and maximum drawdown , to decide if Aprogen Healthcare Games performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aprogen Healthcare Games has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Total Cashflows From Investing Activities | -6.8 B |
Aprogen |
Aprogen Healthcare Relative Risk vs. Return Landscape
If you would invest 70,800 in Aprogen Healthcare Games on August 27, 2024 and sell it today you would lose (23,300) from holding Aprogen Healthcare Games or give up 32.91% of portfolio value over 90 days. Aprogen Healthcare Games is generating negative expected returns and assumes 2.9232% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Aprogen, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Aprogen Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aprogen Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aprogen Healthcare Games, and traders can use it to determine the average amount a Aprogen Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2157
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 109960 |
Estimated Market Risk
2.92 actual daily | 26 74% of assets are more volatile |
Expected Return
-0.63 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aprogen Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aprogen Healthcare by adding Aprogen Healthcare to a well-diversified portfolio.
Aprogen Healthcare Fundamentals Growth
Aprogen Stock prices reflect investors' perceptions of the future prospects and financial health of Aprogen Healthcare, and Aprogen Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aprogen Stock performance.
Return On Equity | 3.02 | |||
Return On Asset | -0.0075 | |||
Profit Margin | 0.17 % | |||
Operating Margin | (0.32) % | |||
Current Valuation | 126 B | |||
Shares Outstanding | 178.7 M | |||
Price To Sales | 7.70 X | |||
Revenue | 8.42 B | |||
EBITDA | (2.33 B) | |||
Cash And Equivalents | 11.53 B | |||
Cash Per Share | 175.12 X | |||
Total Debt | 37.5 M | |||
Debt To Equity | 0 % | |||
Book Value Per Share | 346.53 X | |||
Cash Flow From Operations | (13.29 B) | |||
Total Asset | 226.74 B | |||
Retained Earnings | (512 M) | |||
Current Asset | 5.78 B | |||
Current Liabilities | 5.61 B | |||
About Aprogen Healthcare Performance
By analyzing Aprogen Healthcare's fundamental ratios, stakeholders can gain valuable insights into Aprogen Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aprogen Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aprogen Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aprogen Healthcare Games Inc. engages in the development of medicines using biomedical technology. Aprogen Healthcare Games Inc. was founded in 1998 and is headquartered in Seongnam, South Korea. Aprogen HG is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Aprogen Healthcare Games performance evaluation
Checking the ongoing alerts about Aprogen Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aprogen Healthcare Games help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Aprogen Healthcare generated a negative expected return over the last 90 days | |
Aprogen Healthcare Games has accumulated about 11.53 B in cash with (13.29 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 175.12. | |
Roughly 60.0% of the company shares are owned by insiders or employees |
- Analyzing Aprogen Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aprogen Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Aprogen Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aprogen Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aprogen Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aprogen Healthcare's stock. These opinions can provide insight into Aprogen Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aprogen Stock analysis
When running Aprogen Healthcare's price analysis, check to measure Aprogen Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aprogen Healthcare is operating at the current time. Most of Aprogen Healthcare's value examination focuses on studying past and present price action to predict the probability of Aprogen Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aprogen Healthcare's price. Additionally, you may evaluate how the addition of Aprogen Healthcare to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Transaction History View history of all your transactions and understand their impact on performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |